Penn State Researchers Look to Further Test Cannabinoid Compounds' Anti-Cancer Properties
Top photo: © Alex Traksel | Adobe Stock

Penn State Researchers Look to Further Test Cannabinoid Compounds' Anti-Cancer Properties

Penn State College of Medicine researchers tested the effects of synthetic cannabinoid compounds on colon cancer cells.

Subscribe
February 7, 2019
www.cumberlink.com

Penn State College of Medicine researchers Wednesday said they are looking to further test 10 compounds that were shown to inhibit colon cancer cell growth, though neither of those two compounds are THC and CBD.

Researchers tested the effects of synthetic cannabinoid compounds on colon cancer cells in an experiment in test tubes, according to a news release from Penn State Hershey. Of 370 different synthetic cannabinoid compounds, 10 were found to be effective.

“Now that we’ve identified the compounds that we think have this activity, we can take these compounds and start trying to alter them to make them more potent against cancer cells,” said Kent Vrana, chair of the department of pharmacology at the college. “And then eventually, we can explore the potential for using these compounds to develop drugs for treating cancer.”

Read more